STEAD
Live / Registered — Registered (as of 24 Mar 2026)
What this means for you
Registered since 24 Mar 2026. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97241975
- Registration number
- 8187912
- Mark type
- Stylized text
- Filed
- 27 Jan 2022
- Published for opposition
- 03 Jan 2023
- Registered
- 24 Mar 2026
- Attorney of record
- Keith Toms
Goods and services
- Class 042 — Scientific and technological services: Conducting early evaluations in the field of new pharmaceuticals; research and development of pharmaceutical and biopharmaceutical preparations and medicines; Pharmaceutical and biotechnology products development; Research and development in the pharmaceutical and biotechnology fields; pharmaceutical and biopharmaceutical research services in the fields of cancer and genetic diseases; pharmaceutical and biopharmaceutical research services in the nature of biomarker identification; pharmaceutical and biopharmaceutical research services, namely, artificial intelligence assisted drug discovery and development services
Owner
- GV20 Therapeutics LLC, Newton, MA, US
- GV20 Therapeutics LLC, Newton, MA, US
- GV20 Therapeutics LLC, Cambridge, MA, US
Prosecution history
- 24 Mar 2026 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 24 Mar 2026 — REGISTERED-PRINCIPAL REGISTER
- 27 Feb 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 27 Feb 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 26 Feb 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 25 Feb 2026 — USE AMENDMENT FILED
- 25 Feb 2026 — TEAS STATEMENT OF USE RECEIVED
- 18 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Dec 2025 — SOU EXTENSION 5 GRANTED
- 29 Jul 2025 — SOU EXTENSION 5 FILED
- 18 Dec 2025 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 29 Jul 2025 — SOU TEAS EXTENSION RECEIVED
- 04 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 25 Jan 2025 — SOU EXTENSION 4 GRANTED
- 25 Jan 2025 — SOU EXTENSION 4 FILED